Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD
Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD
Not yet recruiting · NCT07778719 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, metabolic dysfunction-associated steatotic liver disease, type 2 diabetes mellitus | Not yet recruiting | Not applicable | 2026-08-21 | NCT07778719 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The 95th Hospital of Putian，Putian, Fujian, China | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Ethics Committee of Putian 95 Hospital | Putian | China | 2 |